Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Not Confirmed
Not Confirmed
03-05 September, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Industry Trade Show
Not Confirmed
03-05 September, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
06 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/06/3128229/14025/en/Arbutus-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html
25 Jun 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/arbutus-regains-china-rights-potential-functional-hep-b-cure-part-strategic-rethink
25 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/25/3104977/14025/en/Arbutus-Reacquires-Greater-China-Rights-to-Imdusiran-and-Announces-Scientific-Advisory-Board-with-Late-Stage-Clinical-Focus.html
14 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/14/3081038/14025/en/Arbutus-Reports-First-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html
07 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/07/3075762/14025/en/Arbutus-Presents-Clinical-Trial-Data-from-its-Two-HBV-Assets-Imdusiran-and-AB-101-at-the-European-Association-for-the-Study-of-the-Liver-EASL-Congress-2025.html
23 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/23/3066080/14025/en/Arbutus-to-Present-Imdusiran-and-AB-101-Data-at-EASL-Congress-2025.html
ABOUT THIS PAGE